Social Cognition in Children and Adolescents With Autism Spectrum Disorder
A Study of Social Cognition in Children With Autism Spectrum Disorder: Behavioral and Cognitive Assessments With Typically Developing Controls
2 other identifiers
observational
1,000
1 country
1
Brief Summary
This study aims to (1) characterize the multi-domain social cognitive profile and developmental trajectory of children with autism spectrum disorder (ASD) aged 2.5 to 14 years relative to typically developing peers; (2) establish age-referenced normative data for the social cognition assessment battery in a large sample of typically developing children. In the observational component, children with ASD and typically developing controls will undergo a comprehensive assessment battery spanning five domains of social cognition: emotion recognition, theory of mind (ToM), face processing, social communication, and broader social cognitive abilities. Assessments include standardized clinical instruments (ADOS-2, Wechsler intelligence scales), eye-tracking paradigms, and a range of behavioral experimental tasks targeting ToM, empathy, and self-perception. In the normative component, a large sample of typically developing children (target n = 880) will complete the same social cognition assessment battery to establish age-stratified normative reference data. This study is conducted across multiple sites, potentially including international collaborating institutions. Findings will advance the understanding of social cognitive development in ASD and inform the design of scalable, family-implemented interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2025
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2025
CompletedFirst Submitted
Initial submission to the registry
June 22, 2026
CompletedFirst Posted
Study publicly available on registry
July 9, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 30, 2028
July 9, 2026
July 1, 2026
4 years
June 22, 2026
July 7, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Correct on total score of Theory of Mind Task
Proportion of correct responses on researcher-designed Theory of Mind behavioral experimental tasks
Baseline
Secondary Outcomes (2)
Proportion of Fixation Time on Facial Regions of Interest (%)
Baseline
Age-Stratified Mean Score on Theory of Mind Tasks (TD Normative Sample)
Baseline
Study Arms (2)
autism
Subjects in the case group are diagnosed with autism spectrum disorder according to DSM-V and clinical observation.
non-autism
Subjects in the control group are healthy children without serious chronic or congenital diseases.
Eligibility Criteria
The study population consists of two groups of children aged 2.5 to 11 years: a clinical group and a typically developing (TD) control group. The clinical group includes children with a confirmed clinical diagnosis of Autism Spectrum Disorder (ASD), validated by a specialist using DSM-5 criteria. The TD control group comprises age-matched individuals with no history of ASD, other neurodevelopmental conditions, or psychiatric disorders. All participants must have an IQ or Developmental Quotient (DQ) equal to or greater than 70, with no co-occurring intellectual disability, and possess normal or corrected-to-normal vision and hearing. Children with known genetic syndromes, severe neurological disorders (e.g., epilepsy, brain injury), or major trauma within the past 3 months are excluded.
You may qualify if:
- Age between 2 years 6 months and 11 years 11 months, with normative data focusing on 3.0 to 10.0 years.
- Native Mandarin Chinese speaker, capable of understanding and cooperating with the assessment.
- Normal development, with no diagnosed neurodevelopmental disorders.
- Guardian has provided written informed consent.
You may not qualify if:
- Intellectual/Developmental assessment score (IQ/DQ) less than 70.
- Diagnosed with Autism Spectrum Disorder (ASD), Attention-Deficit/Hyperactivity Disorder (ADHD), language impairment, cerebral palsy, or other neurodevelopmental conditions.
- Severe hearing or visual impairment that prevents completion of the assessment.
- History of major psychological or physical trauma within the past 3 months, or significant lack of cooperation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Children's Hospital of Fudan University
Shanghai, Shanghai Municipality, 201102, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Xiu Xu
Children's Hospital of Fudan University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 22, 2026
First Posted
July 9, 2026
Study Start
January 5, 2025
Primary Completion (Estimated)
December 30, 2028
Study Completion (Estimated)
December 30, 2028
Last Updated
July 9, 2026
Record last verified: 2026-07